Rheumatoid Arthritis

Rheumatoid Arthritis News

  • Baricitinib Also Appears Effective in Biologic-refractory RA The selective Janus kinase 1 and 2 inhibitor baricitinib appears also to help patients whose rheumatoid arthritis (RA) has not responded adequately to biologic disease-modifying antirheumatic drugs, according to results from the RA-BEACON randomized trial.
  • Pyoderma Gangrenosum Presentation Differs With Age The clinical manifestation and comorbidities of pyoderma gangrenosum (PG) differ between patients under age 65 and older patients, according to a retrospective study.
 

Rheumatoid Arthritis Perspective

 

Journals